Company Valuation: Profarma Distribuidora de Produtos Farmacêuticos S.A.

Data adjusted to current consolidation scope
Fiscal Period: December 2020 2021 2022 2023 2024 2025
Market Cap 1 747.9 723.4 450 747.9 795.7 1,119
Change - -3.28% -37.8% 66.21% 6.39% 40.68%
Enterprise Value (EV) 1 1,277 1,482 1,291 1,698 1,813 2,286
Change - 16.05% -12.88% 31.53% 6.77% 26.1%
P/E 14.3x 9.25x 5.56x 10.6x 6.95x 9.42x
PBR 0.71x 0.67x 0.38x 0.6x 0.61x 0.83x
PEG - 0.2x 1.62x -0.8x 0.1x 2.46x
Capitalization / Revenue 0.14x 0.11x 0.06x 0.09x 0.08x 0.1x
EV / Revenue 0.23x 0.23x 0.17x 0.2x 0.18x 0.2x
EV / EBITDA 8.52x 9.11x 4.54x 5.74x 5.3x 5.65x
EV / EBIT 9.95x 10.9x 5.09x 6.5x 6.05x 6.53x
EV / FCF -50.4x -136x -22.6x -101x 11.3x 34.7x
FCF Yield -1.98% -0.73% -4.42% -0.99% 8.82% 2.88%
Dividend per Share 2 - 0.2706 0.1733 0.3858 0.575 -
Rate of return - 4.59% 4.72% 6.32% 8.86% -
EPS 2 0.4268 0.6377 0.6596 0.574 0.934 0.9697
Distribution rate - 42.4% 26.3% 67.2% 61.6% -
Net sales 1 5,481 6,413 7,816 8,662 10,154 11,451
EBITDA 1 149.9 162.7 284.2 295.6 342.1 404.5
EBIT 1 128.3 136.3 253.8 261.1 299.7 350.1
Net income 1 52.33 78.19 80.87 70.4 114.6 118.9
Net Debt 1 528.9 758.4 840.9 950 1,017 1,167
Reference price 2 6.100 5.900 3.670 6.100 6.490 9.130
Nbr of stocks (in thousands) 122,611 122,611 122,611 122,611 122,611 122,611
Announcement Date 3/16/21 3/16/22 3/15/23 3/7/24 3/18/25 3/17/26
1BRL in Million2BRL
Estimates


P/E (N) EV / Sales (N) EV / EBITDA (N) Dividend Yield (N) Capi.($)
- - - - 188M
23.25x0.25x14.6x0.4% 106B
24.16x0.23x13.55x0.85% 57.49B
35.83x2.69x24.19x1.69% 22.39B
10.6x0.2x4.76x2.78% 8.26B
13.3x0.95x7.85x2.99% 7.15B
9.72x1.84x5.89x3.52% 6.79B
5.59x0.08x2.45x5.31% 6.24B
24.97x1.14x14.32x3.07% 5.1B
47.47x0.88x16.98x0.12% 4.56B
Average 21.65x 0.92x 11.62x 2.3% 22.4B
Weighted average by Cap. 23.59x 0.59x 14.15x 1.1%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA


  1. Stock Market
  2. Stocks
  3. PFRM3 Stock
  4. Valuation Profarma Distribuidora de Produtos Farmacêuticos S.A.